PlainRecalls
FDA Devices Moderate Class II Terminated

InflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for the visual, qualitative, in vitro detection of elevated levels of the MMP-9 protein in human tears, from patients suspected of having dry eye. InflammaDry is to be used to aid in the diagnosis of dry eye, in conjunction with other methods of clinical evaluation. This test is intended for prescription use at point-of-care sites.

Reported: August 9, 2017 Initiated: June 22, 2017 #Z-2803-2017

Product Description

InflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for the visual, qualitative, in vitro detection of elevated levels of the MMP-9 protein in human tears, from patients suspected of having dry eye. InflammaDry is to be used to aid in the diagnosis of dry eye, in conjunction with other methods of clinical evaluation. This test is intended for prescription use at point-of-care sites.

Reason for Recall

In-house testing revealed the presence of plastic spurs at the tips of some Sample Collectors.

Details

Recalling Firm
Quidel Corporation
Units Affected
1078 kits, 21,560 sample collectors
Distribution
Nationwide Distribution including AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MA, MD, MI, MN, MO, NC, NE, NH, NJ, NY, OH, OK, PA, SC, SD, TX, VA, WA, & WV.
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
InflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for the visual, qualitative, in vitro detection of elevated levels of the MMP-9 protein in human tears, from patients suspected of having dry eye. InflammaDry is to be used to aid in the diagnosis of dry eye, in conjunction with other methods of clinical evaluation. This test is intended for prescription use at point-of-care sites.. Recalled by Quidel Corporation. Units affected: 1078 kits, 21,560 sample collectors.
Why was this product recalled?
In-house testing revealed the presence of plastic spurs at the tips of some Sample Collectors.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 9, 2017. Severity: Moderate. Recall number: Z-2803-2017.